Trial Outcomes & Findings for Gender Difference in Response to Caffeine in Children and Adolescents (NCT NCT02119416)

NCT ID: NCT02119416

Last Updated: 2022-08-17

Results Overview

Heart rate measurements were taken every 10 minutes, following 1 minute of rest with an automated Welch Allen Blood Pressure Cuff. We have reported the data as the peak heart rate after 2 mg/kg.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

101 participants

Primary outcome timeframe

Heart rate was collected every 10 minutes for 60 minutes after the dose of caffeine.

Results posted on

2022-08-17

Participant Flow

Participant milestones

Participant milestones
Measure
1mg/kg Caffeine
Order of Caffeine Administration for Visits 1-6: 1mg/kg then 2mg/kg then 0mg/kg
2mg/kg Caffeine
Order of Caffeine Administration for Visits 1-6: 2mg/kg then 0mg/kg then 1mg/kg
Placebo
Order of Administration for Visits 1-6: 0mg/kg then 1mg/kg then 2mg/kg
Overall Study
STARTED
32
36
33
Overall Study
COMPLETED
30
35
31
Overall Study
NOT COMPLETED
2
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
1mg/kg Caffeine
Order of Caffeine Administration for Visits 1-6: 1mg/kg then 2mg/kg then 0mg/kg
2mg/kg Caffeine
Order of Caffeine Administration for Visits 1-6: 2mg/kg then 0mg/kg then 1mg/kg
Placebo
Order of Administration for Visits 1-6: 0mg/kg then 1mg/kg then 2mg/kg
Overall Study
Protocol Violation
1
1
1
Overall Study
wrong pubertal stage
1
0
1

Baseline Characteristics

Gender Difference in Response to Caffeine in Children and Adolescents

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
1mg/kg Caffeine
n=30 Participants
Order of Caffeine Administration for Visits 1-6: 1mg/kg then 2mg/kg then 0mg/kg
2mg/kg Caffeine
n=35 Participants
Order of Caffeine Administration for Visits 1-6: 2mg/kg then 0mg/kg then 1mg/kg
Placebo
n=31 Participants
Order of Administration for Visits 1-6: 0mg/kg then 1mg/kg then 2mg/kg
Total
n=96 Participants
Total of all reporting groups
Age, Categorical
<=18 years
30 Participants
n=5 Participants
35 Participants
n=7 Participants
31 Participants
n=5 Participants
96 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Continuous
12.2 years
STANDARD_DEVIATION 1.1 • n=5 Participants
12.2 years
STANDARD_DEVIATION 1.1 • n=7 Participants
12.2 years
STANDARD_DEVIATION 1.1 • n=5 Participants
12.2 years
STANDARD_DEVIATION 1.1 • n=4 Participants
Sex: Female, Male
Female
13 Participants
n=5 Participants
17 Participants
n=7 Participants
14 Participants
n=5 Participants
44 Participants
n=4 Participants
Sex: Female, Male
Male
17 Participants
n=5 Participants
18 Participants
n=7 Participants
17 Participants
n=5 Participants
52 Participants
n=4 Participants
Region of Enrollment
United States
30 participants
n=5 Participants
35 participants
n=7 Participants
31 participants
n=5 Participants
96 participants
n=4 Participants

PRIMARY outcome

Timeframe: Heart rate was collected every 10 minutes for 60 minutes after the dose of caffeine.

Heart rate measurements were taken every 10 minutes, following 1 minute of rest with an automated Welch Allen Blood Pressure Cuff. We have reported the data as the peak heart rate after 2 mg/kg.

Outcome measures

Outcome measures
Measure
1mg/kg Caffeine Then 2 mg/kg Then 0 mg/kg
n=30 Participants
Order of Caffeine Administration for Visits 1-6: 1mg/kg then 2mg/kg then 0mg/kg
2mg/kg Caffeine Then 0 mg/kg Then 1 mg/kg
n=35 Participants
Order of Caffeine Administration for Visits 1-6: 2mg/kg then 0mg/kg then 1mg/kg
0 mg/kg Then 1 mg/kg Then 2 mg/kg
n=31 Participants
Order of Administration for Visits 1-6: 0mg/kg then 1mg/kg then 2mg/kg
Peak Heart Rate After 2 mg/kg of Caffeine
73.6 beats per minute
Standard Error 2.32
73.2 beats per minute
Standard Error 1.6
79.6 beats per minute
Standard Error 2.64

PRIMARY outcome

Timeframe: Blood pressure was assessed every 10 minutes for 60 minutes after caffeine was administered.

Population: Participants were randomized to a particular order, but this was a crossover design.

Blood pressure measurements were taken every 10 minutes, following 1 minute of rest with an automated Welch Allen Blood Pressure Cuff. We have reported the peak heart rate after the 2 mg/kg dose of caffeine.

Outcome measures

Outcome measures
Measure
1mg/kg Caffeine Then 2 mg/kg Then 0 mg/kg
n=30 Participants
Order of Caffeine Administration for Visits 1-6: 1mg/kg then 2mg/kg then 0mg/kg
2mg/kg Caffeine Then 0 mg/kg Then 1 mg/kg
n=35 Participants
Order of Caffeine Administration for Visits 1-6: 2mg/kg then 0mg/kg then 1mg/kg
0 mg/kg Then 1 mg/kg Then 2 mg/kg
n=31 Participants
Order of Administration for Visits 1-6: 0mg/kg then 1mg/kg then 2mg/kg
Peak Systolic Blood Pressure
107.6 mmHg
Standard Error 1.82
112.3 mmHg
Standard Error 1.69
109.6 mmHg
Standard Error 2.09

Adverse Events

1mg/kg Caffeine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

2mg/kg Caffeine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Placebo

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jennifer Temple

SUNYBuffalo

Phone: 716-829-5593

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place